Pharmaceutical Companies in United Kingdom (UK)

Bond Chemicals is a Manchester-based global supplier of fine and speciality chemicals, pharmaceutical intermediates, and raw materials for drug development.

We specialize in sourcing alternative commercial sources and custom synthesis, serving a diverse range of clients in the Life Sciences Industry, including those developing drugs across all phases of development.

Bond Chemicals distinguishes itself through its extensive worldwide network of manufacturing partners, offering a comprehensive product range from grammes to multi-tonnes, coupled with a commitment to quality assurance, competitive pricing, and expert technical support.

Founded in 2003, Bond Chemicals operates from its UK headquarters in Warrington, with additional facilities in Dublin (EU) and New Jersey (US), providing seamless supply chain solutions globally.

AMPLY Discovery is a drug and nutraceutical discovery company based in Northern Ireland. A spin-out company from Queen's University Belfast, we use machine learning and AI to discover new therapeutic molecules for hard-to-treat diseases. This includes developing new drugs to replace conventional antibiotics and help tackle AMR. Our discovery platform is designed to mine vast biological datasets in silico and validate hundreds of hits in vitro.

We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.

BDD Pharma combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success. Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers. Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report. We specialise in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.

Pharmacy2U is the UK's first and largest online pharmacy. We're a market leader in the pharmacy world, helping over 750,000 patients in England manage their NHS repeat prescriptions from request through to delivery. For over 20 years, we have used cutting-edge technology alongside our UK-based pharmacists, dispensing specialists, and customer care advisers to help improve the lives of patients. Our Leeds and Leicester -based dispensing facilities distribute over 1 million medication items to patients across England every month. KPMG’s Customer Excellence report recently revealed Pharmacy2U is the UK’s number one brand for experience and value, based on a survey of over 10,000 UK consumers. This accolade cements our position as the nation’s go-to online pharmacy and keeps us committed to further broadening our healthcare offering. Our goal is to make simple and convenient healthcare accessible to all. As well as our repeat prescriptions service, patients can also access: - A one-stop online healthcare shop featuring over 4,000 products - Confidential online GP consultations for a range of conditions - Enhanced pharmacy services such as the NHS New Medicine Service We're an ambitious company with big plans and we're looking for talented individuals to join our team and help us to continue excelling in our field. Our CEO Kevin Heath says, “come and join a team that truly lives by our company values of putting the patient at the heart of everything we do”. Want to help shape the future of online healthcare in the UK? Discover our latest vacancies today.

BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York. *Reach out to us* Email: hello@benevolent.ai Careers: Careers@benevolent.ai Twitter: @benevolent_ai Website: benevolent.com

C4X Discovery aims to become the world's most productive drug discovery engine by exploiting cutting edge technologies to design and create best-in-class small-molecule candidates targeting a range of high value therapeutic areas. The company's goal is to drive returns through early-stage revenue-generating deals with the pharmaceutical industry. C4X Discovery has a state-of-the-art suite of proprietary technologies across the drug discovery process. The company's innovative DNA-based target identification platform (Taxonomy3(R)) utilises human genetic datasets to identify novel patient-specific targets leading to greater discovery productivity and increased probability of clinical success. This is complemented by C4XD's novel drug design platform which comprises two innovative chemistry technologies, Conformetrix and Molplex, that combine 4D molecular shape analyses (based on experimental data) with best-in-class computational chemistry. C4X Discovery is advancing its in-house pipeline that is primarily focused on the high value therapeutic areas of inflammation, neurodegeneration and cancer (including immuno-oncology) with a number of new drug candidates identified and further progress made towards the pre-clinical licensing discussions. In selecting new targets and executing new drug discovery programmes, C4X Discovery focuses on high-value disease areas that are the subject of significant licensing activity and will continue to also maximise value from opportunistic areas such as addiction and diabetes. The Company recently signed a licensing agreement with Indivior for a pre-clinical addiction programme worth up to $294m. The Company was founded as a spin-out from the University of Manchester. t has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically and have enabled C4XD to reach multiple value inflexion points since IPO. Website: www.c4xdiscovery.com Twitter: @C4XDiscovery

CV6 Therapeutics is an early stage drug development company focused on the discovery, development and commercialization of novel combination therapies for the treatment of cancer. For further investment questions or opportunities please contact: information@cv6t.com

F-star, an invoX company, is a clinical-stage biopharmaceutical business pioneering bispecific antibodies in immunotherapy so more people with cancer can live longer and improved lives. F-star is committed to working towards a future free from cancer and other serious diseases through the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in treatments. F-star has four second-generation immunooncology therapeutics in the clinic, each directed against some of the most promising IO targets in drug development, including LAG-3 and CD137. F-star’s proprietary antibody discovery platform is protected by an extensive intellectual property estate, with over 500 granted patents and pending patent applications relating to its platform technology and product pipeline. The Company has attracted multiple partnerships with biopharma targeting significant unmet needs across several areas, including oncology, immunology, and CNS.

Our vision is to deliver “AI Brains” that closely resemble human brains that perceive, understand and continuously learn. We are achieving our vision through deploying AI capabilities closer to human level intelligence through the use of unlabeled data, unsupervised few-shot learning, knowledge consolidation and sharing. We deliver brain-inspired AI solutions that enable our select customers and partners to maximally exploit the functionality and performance of Brain-Sense™ technology to reduce costs and enhance our customers’ end-product and service capabilities - continuous AI learning of new use cases from unlabelled data using only a few reference examples, and transfers this learnt knowledge across multiple devices. This novel technology enables a set of new possibilities that minimizes the need for big data and allows for faster learning and more intelligent AI that adapts to changing real life conditions.

Nuclera is making biology accessible by providing researchers a desktop bioprinter capable to produce genes and proteins in one day. Biological research and drug discovery projects begin with and rely on proteins. However, using traditional methods to obtain proteins of interest can take up to 6 months and often include many trials and failures. What if there was an easier way? At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein Discovery™ system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, allowing rapid progress on protein projects through a benchtop, automated, high-throughput protein access system. Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.

Maintaining musculoskeletal health is the keystone of overall health as we get older. As we age our physical condition gradually deteriorates, leading to loss of strength, fitness and mobility. In most cases, this isn’t due to a simple decision to stop exercising. It is due to the breakdown of musculoskeletal function caused by disease. Musculoskeletal diseases such as osteoarthritis, tendinopathy and lower back pain are the primary causes of disability and early retirement in people over the age of 65. Currently, there are no approved disease-modifying drugs for these diseases, meaning that physical decline in old age is inevitable. At Causeway, we believe that physical decline in old age is not inevitable and in indeed may be reversible. To address this, we are developing a range of therapies that treat common MSK diseases that will allow us to remain fit and active into our nineties and beyond. Staying active as we get older also reduces the risk of developing osteoporosis, dementia, diabetes, obesity, cancer and cardiovascular disease. Finding a way to remain fit and active as we age isn’t just a personal imperative but also a global one. By 2050, one in four of us will be over 65 years old, the number of people age over 80 is projected to triple and retirement age to rise to 75-80 years old. As individuals and as a society, we need to find solutions to the problems of ageing. Our goal is to develop therapies that treat the most common MSK diseases, such as osteoarthritis, tendinopathy and lower back pain, re-defining what old age looks and feels like.

Thank you to everyone who has contributed to our journey and supported us along the way... Welcome to our new brand and the pharmacy of the future, Phlo. The Organised Health brand is being retired but do check us out at Phlo to keep up to date with us. www.wearephlo.com

Our mission is to develop innovative technology and software to improve medicines management, now and in the future. TITAN is an innovative new PMR with complete flexibility over pharmacy processes to improve business effectiveness.

Vetark has changed the landscape of exotic animal nutrition in the UK with its unique vitamin and supplement ranges, addressing the industry‘s need for product efficacy and integrity. All of our products are scientifically based, with the formulations having been developed by RCVS recognised veterinary specialists, and we are proud to be certified to manufacture veterinary medicines under the Exemption for Small Pet Animals (ESPA). Recommended and supplied by vets, Vetark products are now available in over 20 countries worldwide. The product ranges are also used by universities, scientists, and zoos, as well as pet owners.

With over 25 years experience consolidating our position as the leading independent service provider for HPLC, GC, LCMS, GCMS, ICP and ICPMS. LC Services is an independent service organisation formed in 1989 and boasting a full compliment of highly qualified engineers, providing expert care, maintenance and troubleshooting of chromatography systems, with exclusive global OEM Partnerships. Strategically located in the beautiful village of Turvey in Bedfordshire, from where there are excellent transport links to all of the UK nationwide and European clients. LC Services Ltd have some of the most impressive facilities, fully equipment workshops and laboratories in the industry. ◦BS EN ISO 9001 : 2015 ◦ Comprehensive and highly technical staff to serve all our customers efficiently ◦ Geographically based field engineers including our service manager providing immediate attention to our customers ◦ In-house engineers providing services for our exchange/refurbish programme ◦ Account managers on call to discuss your requirements ◦ Optics engineers providing all your lamp and optics needs ◦ In-house staff providing comprehensive backup support, available online, on the phone or in person ◦ Large onsite stock of consumables for global rapid dispatch ◦ 3 x on-site laboratories *NEW ICP Lab (2016)* ◦ Workshop and testing area ◦ Manufacturing/development building ◦ Instrument room ◦ Refurbished exchange modules - some no longer supported by the OEM Focusing on service, support and all your consumable needs for your chromatography equipment allows us to pay attention to all aspects of our customers requirements. We offer various support packages for the requirements of our individual clients: • Various manufacturers supported • Maintenance packages • Training packages • Operational qualification

Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. The company benefits from a close working relationship with the School of Life Sciences at the University of Sussex.

As a pharmacy or dispensing practice owner – your world is getting tougher. So making your purchasing profitable is as critical as it’s ever been. But finding & buying drugs for your patients is opaque, complex and prices are more volatile than ever. For 20 years, Cambrian Alliance has existed to make independents stronger and adapt to the constant change in Pharmacy. With our buying platform e-CASS, you can quickly check prices for products across suppliers, control your over-tariff losses and fine-tune how your team buy every day so you can balance getting prescriptions fulfilled with profit. e-CASS makes it easy to compare, control & make profit on your drug purchasing and as the largest independent buying group, we use our collective strength to negotiate the best prices on more than 25,000 lines for you. Our team of Business and Account Service Managers ensure you and your team are getting the best out of e-CASS’ innovations and profits from your products. Because we are run by pharmacists and dispensers, for you, we are constantly adding to our roadmap of investments.

Pharma IQ, is the international online community focusing on providing pharmaceutical professionals with knowledge, information and insight. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community

Established in 2005, Bioscript Group is formed from multiple, specialist businesses to support our global pharmaceutical clients; we draw on their multidisciplinary expertise to help navigate critical decisions at key points in the product lifecycle. ​ Our scientific and strategic expertise help our clients make better decisions. We provide medical communication services, market access consulting and regulatory writing support with deep domain expertise to effectively navigate complex disease areas.

Verpora is a trusted partner of major life science companies in the development and deployment of value-based pricing and contracting strategies. Developing and implementing a value-based agreement (VBA) that works for all stakeholders is complex and must embrace a wide-range of inputs and influences. It’s a specialist area, and pharma will benefit from professional help. That is why Verpora was created. Verpora is a multi-functional specialist consultancy that has drawn together leading thinkers and practitioners to ensure your VBA project is delivered on time and on spec. Verpora’s holistic and proven approach goes beyond simply developing a contract structure by addressing key touch points such as payer behaviour and commercial team competence/confidence. Founded by experienced payers, data scientists, and industry experts, Verpora can ensure you get the inside track to creating and deploying successful market access strategies.

Our vision is to be the best integrated healthcare provider, wherever we are. For us, this means providing each customer with the best possible products and services. PHOENIX is a large and successful group of companies ensuring patients and the public have access to high-quality healthcare in the UK and across Europe. We specialise in medicine distribution, pharmaceutical care and pharmacy- based primary care services. We work in partnership with the NHS, healthcare commissioners and providers as well as pharmaceutical manufacturers. Our companies include Rowlands Pharmacy, PHOENIX Healthcare Distribution, PSUK, Numark, Nupharm and Nucare. We directly manage over 500 community pharmacies and support over 3,500 others, we deliver over 250 million packs of medicines each year through 13 depots situated across the UK. We employ over 6,000 people who provide support to the 25 million patients who visit our owned and supported pharmacies each year. Across Europe, PHOENIX operates in 26 countries, often as market leader, with 34,000 employees, 14,000+ owned and supported pharmacies, 152 medicine distribution centres, 136 million patient visits and a revenue of £24 billion.

Our primary focus is to provide outstanding patient care and be responsive to the needs of our patients whenever they need us both in Homecare and in the private hospital sector. We achieve this through working closely with trusts and clients and always maintaining a strong line of communication between all parties.

Strategic Consultancy Services for Pharma and Biotech Companies aiming to break into Europe and the UK. We provide a gateway to Europe via our Irish office and a UK presence via our office near London.

Matrix Healthcare Solutions provides unparalleled access to medicines for use in global clinical trials. As the partner of choice for a broad spectrum of pioneering pharmaceutical and biotech companies, we are proud to support the development of the next generation of human medicines. Our rapid growth is directly attributed to the vast knowledge-base held within our team of experts and ability to consistently deliver.

Amercare is a UK market leader in the design, manufacture, and supply of isolators and containment technologies. We are dedicated to enhancing medical and pharmaceutical operations by delivering innovative solutions that protect products, people, and environments. From standard models to fully bespoke solutions, we provide a comprehensive in-house service that includes expert technical advice, custom design, manufacturing, delivery, installation, commissioning, spares, and ongoing servicing. With nationwide coverage, we are committed to supplying equipment that is built, installed, and maintained to the highest standards, ensuring that your operations remain safe, efficient, and compliant. Now proud to be part of the Breeze Group, alongside Contained Air Solutions and BioSpherix, uniting leading expertise and innovation in cleanroom and laboratory solutions.

Core Precision provides expertise across all aspects of drug-diagnostic co-development, regulatory requirements and commercialisation to deliver and implement companion diagnostic strategies that drive the successful development and market uptake of our clients therapies. We bring: • Decades of large pharma and diagnostic expertise in progressing numerous therapies alongside companion diagnostics from discovery through clinical development and successful launch and uptake in markets around the world • Broad experience across various disease areas, diagnostic technologies and drug co-development stages as well as launch readiness and post launch activities • All the expertise needed in one place   Core Precision will partner with you to overcame obstacles and realise the full potential of your therapies towards regulatory and commercial success.

We don’t help you sell to the NHS. We help the NHS buy from you. Cheemia are independent market access and pull-through specialists, working with pharmaceutical clients looking to supply to the NHS. Our mission is to align agendas between NHS and our clients, creating relationships that generate efficiency savings for NHS, increase patient access to quality medicines and rapidly grow our clients’ pharmaceutical brands. We have someone based in each of the four NHS regions - NHS England, NHS Scotland, NHS Wales or NHS Northern Ireland – which means we can be region neutral when it comes to planning a strategy. Aligning agendas for healthier relationships. Say hello and book a confidential chat to discuss your needs. Call 07887 824034

PULSE is a Veeva full-service digital healthcare agency, technology and platform company, working with leading global life sciences, pharmaceutical and healthcare brands. We provide a comprehensive set of solutions to help customers reach, engage and build relationships with healthcare professionals, patients, consumers and shoppers. Our efficient and cost effective industry-leading cloud solution Heartbeat™ Veeva Content Authoring Solution, helps customers to create and deliver compliant and personalised Veeva content at scale, by accelerating approvals and driving content adoption and reuse of assets.

We believe everyone should have the opportunity to live in rude health. That’s why we specialize in healthcare communications that help people to make informed decisions that ultimately improve human health. With principal offices in the UK and China, together with an extended network in Europe, Asia and North America, our teams combine a global and local perspective to challenge current thinking. We engage with medical, scientific and patient communities to further healthcare understanding by developing effective solutions for our clients. Our work is underpinned by medical excellence and strategic know how – driven by our mission to educate and empower people to live in rude health.

Extract Technology has over 70 years of engineering heritage in aseptic and containment systems for pharmaceutical, biopharmaceutical, nuclear containment, and radiopharmaceutical applications. In 2021 Extract Technology became part of the Dec Group family of companies, enhancing the Groups Containment technology platform. Manufacturing Dec Group products at it’s Huddersfield, UK site, Extract Technology is known for innovation in aseptic and containment isolators and downflow booth technology for a broad range of pharmaceutical applications. Extract Technology specializes in isolators and downflow booths with process integrations including for use in pharmaceutical manufacturing, cell and gene therapy processing, sterility testing and liquid and powder filling, and research and development. Equipment solutions from Extract Technology also include modular cleanrooms, cell therapy processing isolators, LAF Carts, RABS, and lab benches. The Walker Barrier Systems brand serves nuclear containment, government, and defense clientele with glovebox and hot cells manufactured under a strict NQA-1 quality program. Contact the team: info@extract-technology.com

One-day expertly-curated events offering highly-interactive, limited-capacity, focused roundtables (Xchanges), 1:1 meetings, and unparalleled networking for C-suite executives and senior scientists, addressing key life science (Pharma/Biotech) topics across North America and Europe.

We are science communication specialists. At Enzyme Communications we offer organisations in the science and healthcare industries agency services. From brand strategy, to product launch and communications materials, we can help you turn science into stories and data into evidence-based arguments.

Kinesys provides Strategic & Operational Regulatory Affairs Services. This extends to Strategic Planning & Writing for all types of Applications: – Scientific Advice, – Orphans, – CTA/IND, – PIPs/iPSP, – Early Access/Expedited Pathways (PRIME, BT, PIM etc.) – & MAA. We are experts in Hemato-oncology, Neurology & Rare Diseases and our experience covers NCEs, biologics, ATMPs & devices. We have a unique platform, EMA Solutions, of ex-EMA & other EU Agency experts to support clients at critical timepoints.

Join our training for Pharma Execs on AI: https://eularis.com/ai-training-for-pharma/ We innovate to solve pharma/biotech/med device business challenges using AI to maximize our clients’ measurable results. We have been in business since 2003 and were the first company to use AI in pharma, and continue to lead in innovation with the projects we participate in. Our teams consist of pharma business strategists, data scientists, big data engineers, full stack developers, computational linguists and user interface designers. Example projects we have done that are powered by AI include: *Finding rare disease patients using AI *Creating chatbots to guide teams to insights in mountains of power point results data *Earlier patient diagnosis *Identifying patients for clinical trials *Personalized individual content and channel delivery to each HCP or patient for maximum engagement *Personalized sales messages by individual physician for sales reps *Hastening reimbursement to formularies *Value based drug pricing Whether you want us to plan a strategy, or do a full end-to-end implementation, or just help with niggling problems your team cannot solve, we are here to help.

Essential Pharma is an international specialty pharmaceutical company dedicated to maintaining access to clinically differentiated, niche medicines in small patient populations. Our high-impact portfolio has a focus on the central nervous system (CNS), gastroenterology, ophthalmology, and rare disease, and our products treat patients in more than 70 countries. We are proactive in identifying low volume, difficult-to-manufacture therapeutic products, and late-stage clinical development assets that target rare diseases. We specialise in the acquisition of mature, established, branded medicines that are at risk of shortages or discontinuation, working with partners across the globe to ensure their continued manufacture to the highest standards. Essential Pharma comprises innovative and driven people who are passionate about ensuring continued supply of medicines to patients. We are committed to living by our values – Collaborative, Responsible, Trustworthy and Dynamic – and pride ourselves on our inclusive culture, where everyone's voice is valued and respected. We have an unwavering dedication to employee growth and believe in fostering an environment where all individuals can thrive. Watch our video to see why employees love working at Essential Pharma, and explore our current vacancies on the Careers Page here: https://essentialpharmagroup.com/careers/

Established in 2005 Cuttlefish is a pharmaceutical company that provides manufacturing expertise to the pharmaceutical, biotechnology and healthcare sectors. Cuttlefish has proven experience in outsourcing and cost reduction. Our customer base includes small and medium sized companies as well as global organizations. We hold MHRA and VMD wholesale dealer licences.

deepmatter® is a chemical data company that liberates chemists to capture, record and discover together on a global scale with our range of products: DigitalGlassware® brings recordability, reproducibility and shareability to your lab at every stage of the discovery process, from planning your chemistry to analysing the outcome. ICSYNTH is a synthesis design tool that enables chemists to generate synthetic pathways for target molecules, stimulating ideas for alternative or novel synthetic routes that otherwise may not be considered. Our Mining for Chemistry offering helps you to annotate structures and semantically enrich your Chemistry and Life Sciences documents and data. deepmatter® also offers a broad selection of software tools and applications to solve any problem in the field of chemical data management, focusing in particular on high performance and reliability in handling and management of large chemical data sets. All deepmatter® solutions are very flexible and can therefore be integrated into customer pre-existing infrastructures, which is an important aspect as research organizations design more comprehensive and integrated environments for successful discovery.

Holiferm is bringing biosurfactants to market and is in the process of building a ktonne scale sophorolipid manufacturing plant.

Aurum Biosciences Ltd is a clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS). Follow-on indications include heart disease, oncology, inflammatory conditions, spinal cord injury, and dementia. Preclinical development has been completed in the lead indication (AIS) and approval has been granted to initiate clinical studies in acute stroke patients. Concurrently, Aurum is pursuing opportunities to develop its pipeline indications with a focus on inflammatory conditions and oncology.

Established in 2012, Simple Online Pharmacy has become one of the leading online pharmacies in the UK. It is now one of the fastest-growing internet pharmacies in the UK, with several service offerings to patients. It provides for NHS repeat prescriptions, pharmacy medicines, over the counter medicines, and online doctor consultations. Medications are delivered straight to your doorstep without having to leave the comfort of your own home. We are proud of our record of passing savings to our patients, and many of our prices are the lowest on both the high street and other online competitors. Investment in technology and patient care is allowing Simple Online Pharmacy to fuel further growth. Aiming to match and surpass the level of care patients receive on the high street is the aim, to make internet pharmacy a better and more convenient alternative for patients.  Simple Online Pharmacy is run by pharmacists and operates to the highest professional standards. It is registered with the General Pharmaceutical Council (GPhC), Health Improvement Scotland (HIS) and holds 3 NHS pharmacy contracts in cities across the UK. In total, Simple Online Pharmacy has 4 pharmacies, across London, Glasgow and Aberdeen. Changes in how healthcare is delivered means that the delivery of online telehealth services is now more accepted and adopted than ever. 

At CheqUp we think everyone should be health positive. Whether you’re concerned or just want peace of mind, our tests are easy, fast and convenient so health isn’t something that happens to you, it’s something you control.

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development manufacture and sales of high-quality products exclusively for veterinarians worldwide. We are driven by our purpose of the sustainable improvement of global animal health and welfare. We have sales and marketing organisations in 26 countries and market our products in 63 other countries worldwide through distributors or marketing partners. We see things from The Veterinary Perspective. We continue to grow because we understand the challenges veterinarian face. We provide training, support and information that helps them help animals. Accessible science that enables vets to communicate with owners and farmers better. It’s this perspective that makes us a preferred supplier. Understanding customers is built into our business model. We give veterinarians what they need, from everyday evidence-based treatments to knowledge on rarer diseases. To ensure our growth, we’re not just an animal pharma company. We’re the veterinary professional’s pharma company. #TheVeterinaryPerspective. Find out more about our company on our company website www.dechra.com

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 20 of the top 20 pharmaceutical companies. We have earned the reputation of a best-in-class partner for medical affairs teams, with expertise in leading medical strategy, medical communications, publication planning & delivery, patient engagement, and more. And through our comprehensive suite of services and industry-leading technology solutions - including Two Labs, Okra.ai, Riparian, and 90TEN - we support clients across the product life cycle. Clients come to us for expertise in artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Our purpose-built software, scientific solutions, and behavior change expertise make us a unique partner to the pharmaceutical industry.

Alderley Analytical is an independent Contract Research Organisation (CRO). We offer specialist bioanalytical services to support your drug development programmes, from discovery through to late stage clinical development, focusing on small molecules, large molecules, peptides, biologics and biomarkers. Our biotech, pharma and CRO clients have discovered that keeping their bioanalysis with one provider means fewer laboratory transfers and no loss of bioanalytical knowledge of the molecule. By simplifying this process, it means less complications helping the rapid development of new drugs. We take a flexible and responsive approach, using our collective expertise to develop novel bioanalytical methods and deliver your results on-time to the right quality. We also pride ourselves on excellent communication; you’ll find us easy to get hold of and we stay in touch, even if there’s no news to report. As a GLP and GCP accredited laboratory, we can offer regulatory compliance where needed and are able to validate bioanalytical methods and deliver bioanalytical results to current FDA/EMA guidelines. Get in touch to discuss your bioanalysis requirements today. Visit our website at www.alderleyanalytical.com for more information.

See attached. The company information to follow. The website is still under construction and should be live by the ends of the month. Services are also being planned and should be launched by February

Founded in 2008, Indigo Medical is one of the fastest growing medical affairs firms based in the UK. We provide 4 main services to our pharmaceutical clients: 1. Medical and scientific communications and medical education 2. ABPI-guided compliance material review and approval services (utilising our dedicated in-house team of reviewers and nominated signatories) 3. Compliance Code Training & Education (face-to-face and offline) 4. Engagement via our Meetings & Events service IT ALL STARTS WITH A GOOD CONVERSATION… Talk to us about where you want to go and we can join you on your journey. www.indigomedical.co.uk

Alliance Healthcare, a part of Cencora (formerly AmerisourceBergen, is a leading international provider of pharmaceutical wholesaling, logistics, support with clinical trials and other innovative healthcare services and solutions to independent pharmacists and pharmaceutical manufacturers across Europe and beyond.

Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe, the US, Canada, and Australia. Our Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network complement our global operations. ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines, specialty generics & biosimilars, and originator brands. Our products and pipeline cover a broad range of therapeutic areas, including hepatology, gastroenterology, anti-infectives, critical care, endocrinology, CNS, and, more broadly, rare diseases. We can only achieve our ambition with the passion of our dedicated and highly qualified people, acting in line with our company values of entrepreneurship, speed, and integrity.